Cargando…

Baseline neuropsychological profiles in prion disease predict survival time

OBJECTIVE: Few studies have captured the neuropsychological profile of sporadic Creutzfeldt–Jakob disease (sCJD) with neuropsychological testing, and little is known about cognitive predictors of survival. We characterized baseline neuropsychological performance in sCJD and investigated associations...

Descripción completa

Detalles Bibliográficos
Autores principales: Sundaram, Saranya E., Staffaroni, Adam M., Walker, Nicole C., Casaletto, Kaitlin B., Casey, Megan, Golubjatnikov, Aili, Metcalf, Stacy, O’Leary, Kelly, Wong, Katherine, Benisano, Kendra, Forner, Sven, Gonzalez Catalan, Marta, Allen, Isabel E., Rosen, Howard J., Kramer, Joel H., Geschwind, Michael D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480924/
https://www.ncbi.nlm.nih.gov/pubmed/33314770
http://dx.doi.org/10.1002/acn3.51115
_version_ 1783580500044021760
author Sundaram, Saranya E.
Staffaroni, Adam M.
Walker, Nicole C.
Casaletto, Kaitlin B.
Casey, Megan
Golubjatnikov, Aili
Metcalf, Stacy
O’Leary, Kelly
Wong, Katherine
Benisano, Kendra
Forner, Sven
Gonzalez Catalan, Marta
Allen, Isabel E.
Rosen, Howard J.
Kramer, Joel H.
Geschwind, Michael D.
author_facet Sundaram, Saranya E.
Staffaroni, Adam M.
Walker, Nicole C.
Casaletto, Kaitlin B.
Casey, Megan
Golubjatnikov, Aili
Metcalf, Stacy
O’Leary, Kelly
Wong, Katherine
Benisano, Kendra
Forner, Sven
Gonzalez Catalan, Marta
Allen, Isabel E.
Rosen, Howard J.
Kramer, Joel H.
Geschwind, Michael D.
author_sort Sundaram, Saranya E.
collection PubMed
description OBJECTIVE: Few studies have captured the neuropsychological profile of sporadic Creutzfeldt–Jakob disease (sCJD) with neuropsychological testing, and little is known about cognitive predictors of survival. We characterized baseline neuropsychological performance in sCJD and investigated associations with survival. METHODS: sCJD participants who completed the MMSE (n = 118), 61 sCJD of whom also completed a neuropsychological battery at baseline, and 135 age‐matched healthy controls, were included. Composite scores of global cognition, memory, executive functions, visuospatial, and language were derived. Cox proportional hazard models estimated survival time, controlling for age and education. Additional models adjusted for Barthel Index and PRNP codon 129 polymorphism. RESULTS: sCJD participants performed significantly worse than controls on all cognitive tasks and composites with most showing very large effect sizes. The three tests showing the largest group differences were delayed verbal recall (Hedges’g = 4.08, P < 0.0001), Stroop Inhibition (Hedges’g = 3.14, P < 0.0001), and Modified Trails (Hedges’g = 2.94, P < 0.0001). Memory (95%) and executive functioning (87%) composites were most commonly impaired. Poorer global (HR = 0.65, P < 0.0001), visuospatial (HR = 0.82, P < 0.0001), and memory (HR = 0.82, P = 0.01) composites predicted shorter survival. Visuospatial cognition remained a significant predictor even after adjusting for all other cognitive composites; each standard deviation decrease in visuospatial cognition was associated with an 18% higher chance of death (HR = 0.82, P < 0.003). Global (HR = 0.68, P = 0.03) and visuospatial (HR = 0.82, P = 0.001) composites remained significant predictors after controlling for Barthel Index and codon 129. INTERPRETATION: sCJD participants exhibit a broad range of cognitive impairments, with memory and executive functioning deficits in the vast majority. Neuropsychological assessment, particularly of visuospatial abilities, informs prognostication in sCJD.
format Online
Article
Text
id pubmed-7480924
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-74809242020-09-16 Baseline neuropsychological profiles in prion disease predict survival time Sundaram, Saranya E. Staffaroni, Adam M. Walker, Nicole C. Casaletto, Kaitlin B. Casey, Megan Golubjatnikov, Aili Metcalf, Stacy O’Leary, Kelly Wong, Katherine Benisano, Kendra Forner, Sven Gonzalez Catalan, Marta Allen, Isabel E. Rosen, Howard J. Kramer, Joel H. Geschwind, Michael D. Ann Clin Transl Neurol Research Articles OBJECTIVE: Few studies have captured the neuropsychological profile of sporadic Creutzfeldt–Jakob disease (sCJD) with neuropsychological testing, and little is known about cognitive predictors of survival. We characterized baseline neuropsychological performance in sCJD and investigated associations with survival. METHODS: sCJD participants who completed the MMSE (n = 118), 61 sCJD of whom also completed a neuropsychological battery at baseline, and 135 age‐matched healthy controls, were included. Composite scores of global cognition, memory, executive functions, visuospatial, and language were derived. Cox proportional hazard models estimated survival time, controlling for age and education. Additional models adjusted for Barthel Index and PRNP codon 129 polymorphism. RESULTS: sCJD participants performed significantly worse than controls on all cognitive tasks and composites with most showing very large effect sizes. The three tests showing the largest group differences were delayed verbal recall (Hedges’g = 4.08, P < 0.0001), Stroop Inhibition (Hedges’g = 3.14, P < 0.0001), and Modified Trails (Hedges’g = 2.94, P < 0.0001). Memory (95%) and executive functioning (87%) composites were most commonly impaired. Poorer global (HR = 0.65, P < 0.0001), visuospatial (HR = 0.82, P < 0.0001), and memory (HR = 0.82, P = 0.01) composites predicted shorter survival. Visuospatial cognition remained a significant predictor even after adjusting for all other cognitive composites; each standard deviation decrease in visuospatial cognition was associated with an 18% higher chance of death (HR = 0.82, P < 0.003). Global (HR = 0.68, P = 0.03) and visuospatial (HR = 0.82, P = 0.001) composites remained significant predictors after controlling for Barthel Index and codon 129. INTERPRETATION: sCJD participants exhibit a broad range of cognitive impairments, with memory and executive functioning deficits in the vast majority. Neuropsychological assessment, particularly of visuospatial abilities, informs prognostication in sCJD. John Wiley and Sons Inc. 2020-09-09 /pmc/articles/PMC7480924/ /pubmed/33314770 http://dx.doi.org/10.1002/acn3.51115 Text en © 2020 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Sundaram, Saranya E.
Staffaroni, Adam M.
Walker, Nicole C.
Casaletto, Kaitlin B.
Casey, Megan
Golubjatnikov, Aili
Metcalf, Stacy
O’Leary, Kelly
Wong, Katherine
Benisano, Kendra
Forner, Sven
Gonzalez Catalan, Marta
Allen, Isabel E.
Rosen, Howard J.
Kramer, Joel H.
Geschwind, Michael D.
Baseline neuropsychological profiles in prion disease predict survival time
title Baseline neuropsychological profiles in prion disease predict survival time
title_full Baseline neuropsychological profiles in prion disease predict survival time
title_fullStr Baseline neuropsychological profiles in prion disease predict survival time
title_full_unstemmed Baseline neuropsychological profiles in prion disease predict survival time
title_short Baseline neuropsychological profiles in prion disease predict survival time
title_sort baseline neuropsychological profiles in prion disease predict survival time
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480924/
https://www.ncbi.nlm.nih.gov/pubmed/33314770
http://dx.doi.org/10.1002/acn3.51115
work_keys_str_mv AT sundaramsaranyae baselineneuropsychologicalprofilesinpriondiseasepredictsurvivaltime
AT staffaroniadamm baselineneuropsychologicalprofilesinpriondiseasepredictsurvivaltime
AT walkernicolec baselineneuropsychologicalprofilesinpriondiseasepredictsurvivaltime
AT casalettokaitlinb baselineneuropsychologicalprofilesinpriondiseasepredictsurvivaltime
AT caseymegan baselineneuropsychologicalprofilesinpriondiseasepredictsurvivaltime
AT golubjatnikovaili baselineneuropsychologicalprofilesinpriondiseasepredictsurvivaltime
AT metcalfstacy baselineneuropsychologicalprofilesinpriondiseasepredictsurvivaltime
AT olearykelly baselineneuropsychologicalprofilesinpriondiseasepredictsurvivaltime
AT wongkatherine baselineneuropsychologicalprofilesinpriondiseasepredictsurvivaltime
AT benisanokendra baselineneuropsychologicalprofilesinpriondiseasepredictsurvivaltime
AT fornersven baselineneuropsychologicalprofilesinpriondiseasepredictsurvivaltime
AT gonzalezcatalanmarta baselineneuropsychologicalprofilesinpriondiseasepredictsurvivaltime
AT allenisabele baselineneuropsychologicalprofilesinpriondiseasepredictsurvivaltime
AT rosenhowardj baselineneuropsychologicalprofilesinpriondiseasepredictsurvivaltime
AT kramerjoelh baselineneuropsychologicalprofilesinpriondiseasepredictsurvivaltime
AT geschwindmichaeld baselineneuropsychologicalprofilesinpriondiseasepredictsurvivaltime